Literature DB >> 23832571

Platelet-rich plasma and the elimination of neuropathic pain.

Damien P Kuffler1.   

Abstract

Peripheral neuropathic pain typically results from trauma-induced nociceptive neuron hyperexcitability and their spontaneous ectopic activity. This pain persists until the trauma-induced cascade of events runs its full course, which results in complete tissue repair, including the nociceptive neurons recovering their normal biophysical properties, ceasing to be hyperexcitable, and stopping having spontaneous electrical activity. However, if a wound undergoes no, insufficient, or too much inflammation, or if a wound becomes stuck in an inflammatory state, chronic neuropathic pain persists. Although various drugs and techniques provide temporary relief from chronic neuropathic pain, many have serious side effects, are not effective, none promotes the completion of the wound healing process, and none provides permanent pain relief. This paper examines the hypothesis that chronic neuropathic pain can be permanently eliminated by applying platelet-rich plasma to the site at which the pain originates, thereby triggering the complete cascade of events involved in normal wound repair. Many published papers claim that the clinical application of platelet-rich plasma to painful sites, such as muscle injuries and joints, or to the ends of nerves evoking chronic neuropathic pain, a process often referred to as prolotherapy, eliminates pain initiated at such sites. However, there is no published explanation of a possible mechanism/s by which platelet-rich plasma may accomplish this effect. This paper discusses the normal physiological cascade of trauma-induced events that lead to chronic neuropathic pain and its eventual elimination, techniques being studied to reduce or eliminate neuropathic pain, and how the application of platelet-rich plasma may lead to the permanent elimination of neuropathic pain. It concludes that platelet-rich plasma eliminates neuropathic pain primarily by platelet- and stem cell-released factors initiating the complex cascade of wound healing events, starting with the induction of enhanced inflammation and its complete resolution, followed by all the subsequent steps of tissue remodeling, wound repair and axon regeneration that result in the elimination of neuropathic pain, and also by some of these same factors acting directly on neurons to promote axon regeneration thereby eliminating neuropathic pain.

Entities:  

Mesh:

Year:  2013        PMID: 23832571     DOI: 10.1007/s12035-013-8494-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  229 in total

1.  Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization?

Authors:  Chong Shen; Gert de Hertogh; Dominique M A Bullens; Gert Van Assche; Karel Geboes; Paul Rutgeerts; Jan L Ceuppens
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

Review 2.  Shoulder pain.

Authors:  Richard J Murphy; Andrew J Carr
Journal:  BMJ Clin Evid       Date:  2010-07-22

3.  Neurological recovery across a 12-cm-long ulnar nerve gap repaired 3.25 years post trauma: case report.

Authors:  Damien P Kuffler; Onix Reyes; Ivan J Sosa; Jose Santiago-Figueroa
Journal:  Neurosurgery       Date:  2011-12       Impact factor: 4.654

4.  Correlations among serum calcium, vitamin D and parathyroid hormone levels in the elderly in southern Taiwan.

Authors:  Wan-Ping Lee; Li-Wei Lin; Shu-Hui Yeh; Rosa Huang Liu; Cheun-Fen Tseng
Journal:  J Nurs Res       Date:  2002-03       Impact factor: 1.682

Review 5.  Hyperbaric oxygen therapy for chronic wounds.

Authors:  Peter Kranke; Michael H Bennett; Marrissa Martyn-St James; Alexander Schnabel; Sebastian E Debus
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

6.  Microglial responses around intrinsic CNS neurons are correlated with axonal regeneration.

Authors:  Bahman N Shokouhi; Bernadette Z Y Wong; Samir Siddiqui; A Robert Lieberman; Gregor Campbell; Koujiro Tohyama; Patrick N Anderson
Journal:  BMC Neurosci       Date:  2010-02-05       Impact factor: 3.288

7.  Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats.

Authors:  Kevin R Novak; Paul Nardelli; Tim C Cope; Gregory Filatov; Jonathan D Glass; Jaffar Khan; Mark M Rich
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

8.  Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model.

Authors:  Erhan Emel; Selma Sönmez Ergün; Dilcan Kotan; Esra Başar Gürsoy; Yeşim Parman; Asli Zengin; Asiye Nurten
Journal:  J Neurosurg       Date:  2010-10-29       Impact factor: 5.115

9.  Vanilloid receptor TRPV1 is not activated by vanilloids applied intracellularly.

Authors:  Ladislav Vyklický; Alla Lyfenko; Damien P Kuffler; Viktorie Vlachová
Journal:  Neuroreport       Date:  2003-05-23       Impact factor: 1.837

10.  Platelet-rich plasma peptides: key for regeneration.

Authors:  Dolores Javier Sánchez-González; Enrique Méndez-Bolaina; Nayeli Isabel Trejo-Bahena
Journal:  Int J Pept       Date:  2012-02-22
View more
  18 in total

Review 1.  Platelet-Rich Plasma Promotes Axon Regeneration, Wound Healing, and Pain Reduction: Fact or Fiction.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2015-06-06       Impact factor: 5.590

Review 2.  Platelet gel: a new therapeutic tool with great potential.

Authors:  Andrea Piccin; Angela M Di Pierro; Lucia Canzian; Marco Primerano; Daisy Corvetta; Giovanni Negri; Guido Mazzoleni; Günther Gastl; Michael Steurer; Ivo Gentilini; Klaus Eisendle; Fabrizio Fontanella
Journal:  Blood Transfus       Date:  2016-07-25       Impact factor: 3.443

Review 3.  Spinal Cord Stimulation, MILD Procedure, and Regenerative Medicine, Novel Interventional Nonopioid Therapies in Chronic Pain.

Authors:  Ken P Ehrhardt; Susan M Mothersele; Andrew J Brunk; Jeremy B Green; Mark R Jones; Craig B Billeaud; Alan David Kaye
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

4.  Mean platelet volume (MPV) predicts middle distance running performance.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Elisa Danese; Spyros Skafidas; Cantor Tarperi; Gian Cesare Guidi; Federico Schena
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

5.  Efficacy of platelet-rich plasma as an adjuvant to surgical carpal ligament release: a prospective, randomized controlled clinical trial.

Authors:  Marian Vila-Caballer; Juan Francisco Lisón; Carmen Trull-Ahuir; Diego Sala; Joaquín Chismol-Abad
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

6.  Effect of Platelet-Rich Plasma Injection on Mild or Moderate Carpal Tunnel Syndrome: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Chunke Dong; Yan Sun; Yingna Qi; Yuting Zhu; Hongyu Wei; Di Wu; Chungen Li
Journal:  Biomed Res Int       Date:  2020-11-14       Impact factor: 3.411

7.  Therapeutic Efficacy of Urethral Sphincter Injections of Platelet-Rich Plasma for the Treatment of Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency: A Proof-of-Concept Clinical Trial.

Authors:  Yuang-Hong Jiang; Ping-Jui Lee; Hann-Chorng Kuo
Journal:  Int Neurourol J       Date:  2021-01-19       Impact factor: 2.835

Review 8.  Recurrent urinary tract infection in women and overactive bladder - Is there a relationship?

Authors:  Qian-Sheng Ke; Cheng-Ling Lee; Hann-Chorng Kuo
Journal:  Tzu Chi Med J       Date:  2020-06-29

9.  Platelet-Rich Plasma Injection in Burn Scar Areas Alleviates Neuropathic Scar Pain.

Authors:  Shu-Hung Huang; Sheng-Hua Wu; Su-Shin Lee; Yun-Nan Lin; Chee-Yin Chai; Chung-Sheng Lai; Hui-Min David Wang
Journal:  Int J Med Sci       Date:  2018-01-08       Impact factor: 3.738

10.  STITCHLESS Percutaneous Endoscopic Cervical Discectomy: Are We Moving Towards Day Care Discectomy Procedure?

Authors:  Sunil M Nadkarni; Pavankumar Kohli; Bhupesh Patel; Satishchandra Gore; Bhagyashree S Kulkarni
Journal:  Indian J Orthop       Date:  2017 Nov-Dec       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.